Question 1

What is Coherus BioSciences?

Accepted Answer

Coherus BioSciences is a Company.

Question 2

How often does Coherus BioSciences appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 12 articles.

Question 3

When was Coherus BioSciences first tracked by Ergen?

Accepted Answer

First tracked on Apr 27, 2026.

Question 4

When was Coherus BioSciences last mentioned in news?

Accepted Answer

Last active on Jul 22, 2026.

Question 5

What is Coherus BioSciences's current news sentiment?

Accepted Answer

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Coherus BioSciences in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Coherus BioSciences?

Accepted Answer

Coherus Q2 2026 results release (Jul 22, 2026, 6 articles).

Question 8

How did the "Coherus Q2 2026 results release" event impact Coherus BioSciences?

Accepted Answer

Coherus is the subject of the event; it announced the timing of its Q2 2026 earnings release and conference call.

Question 9

How did the "NervGen Pharma Appoints Keith Vendola CFO" event impact Coherus BioSciences?

Accepted Answer

Keith Vendola previously held roles including Chief of Staff to the CEO and Vice President of Competitive Strategy and Investor Relations at Coherus BioSciences.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.